Arm Announces Launch of IPO Roadshow


Arm Holdings plc (“Arm”) has commenced its initial public offering (IPO) roadshow for American depositary shares (ADSs) representing its regular shares. The IPO sees a total of 95.5 million ADSs on offer, courtesy of its selling shareholder, a subsidiary of SoftBank Group Corp. Additionally, an over-allotment option may grant underwriters an extra 7 million ADSs within a 30-day window post-final prospectus. The anticipated IPO price per ADS ranges from $47 to $51. Arm plans to list the ADSs on the Nasdaq Global Select Market using the ticker “ARM”.

Raine Securities LLC is the financial advisor for this IPO. Joint book-running managers include Barclays, Goldman Sachs & Co. LLC, J.P. Morgan, and Mizuho, with specific roles assigned to each in the IPO process.

Interested parties can access the preliminary prospectus from the U.S. Securities and Exchange Commission’s (SEC) website or request it from the involved financial institutions.

Though a registration statement has been filed with the SEC, it is not yet active. The offering and selling of securities will be in compliance with the U.S. Securities Act of 1933. Finalization of the IPO is contingent on market conditions and the conclusion of the SEC review process.

Forward-Looking Statements Notice: This release includes predictions and anticipations about the IPO’s specifics and outcomes. Numerous uncontrollable factors might cause the actual outcomes to vary from these forward-looking statements. The IPO’s completion is also susceptible to various conditions.

About Arm: Arm is a pioneering force in advanced computing technology. With its energy-efficient designs and platforms present in over 250 billion chips, Arm’s innovations are omnipresent—from everyday devices to supercomputers. Teaming up with over 1,000 tech partners, Arm’s influence is felt across various domains such as AI and cybersecurity. The company’s ethos revolves around the belief that the future is constructed on Arm’s technology.

For comprehensive details and disclaimers, refer to the original document. All rights, including Arm’s registered trademark, are reserved.

Related Posts

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?